I still question why Roche hasn't already partnered with them for their follow-on nukes, if not otherwise bought VRUS out. Perhaps one of those events is coming soon or is there something else at play?
Roche had the option to license PSI-7851 and it's pro-drugs (PSI-7977) which expired March 31, 2007. In hindsight a huge mistake.
Market Data 
Markets 
AI
